David Walker

1.2k citations

53 papers · 753 indexed · 1 hit paper · h-index 11

Impact in

Rheumatology top 2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
Hematology top 5%
- Autoimmune and Inflammatory Disorders Research

Papers in ⓘ

Rheumatology 27
- Rheumatoid Arthritis Research and Therapies 22
- Systemic Lupus Erythematosus Research 5
Genetics 16
- Chronic Lymphocytic Leukemia Research 14
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4

Co-authors: Peta Heslop (10 shared papers)Ying Guo (10 shared papers)Beatrix Bartók (10 shared papers)Kenneth Kalunian (8 shared papers)Tsutomu Takeuchi (8 shared papers)Chantal Tasset (7 shared papers)Jie Gao (5 shared papers)Andrew Hassell (8 shared papers)
Journals: Lara D. Veeken (16 papers)Annals of the Rheumatic Diseases (6 papers)Musculoskeletal Care (6 papers)Clinical Rheumatology (4 papers)Journal of Crohn s and Colitis (2 papers)
Partner nations: United Kingdom United States France

In The Last Decade

David Walker

47 papers receiving 733 citations

Hit Papers

align trajectories log scale

Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy 2019 · 224 citations

Peers

Countries citing papers authored by David Walker

Since Specialization

Citations

This map shows the geographic impact of David Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Walker more than expected).

Fields of papers citing papers by David Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Walker. The network helps show where David Walker may publish in the future.

Co-authors

The 25 scholars most cited alongside David Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Walker Line = papers co-authored together David Walker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy JAMA ·Mark C. Genovese, Kenneth Kalunian, Jacques‐Eric Gottenberg, Neelufar Mozaffarian, Beatrix Bartók, F. Matzkies, Jie Gao, Ying Guo, Chantal Tasset, John S. Sundy, Kurt de Vlam, David Walker, Tsutomu Takeuchi Hit paper breakdown →	2019	224
2	Effect of the early use of the anti–tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis Arthritis Care & Research ·Victoria Bejarano, Mark Quinn, Philip G. Conaghan, Richard J. Reece, Anne‐Maree Keenan, David Walker, Andrew Gough, Michael Green, Dennis McGonagle, Ade Adebajo, Stephen Jarrett, Sheelagh Doherty, Lesley Hordon, R D Melsom, Kristina Unnebrink, H. Küpper, Paul Emery	2008	136
3	Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis Annals of the Rheumatic Diseases ·Ernest Choy, Colin M. Smith, Vernon T. Farewell, David Walker, Andrew Hassell, Lucy Chau, David L. Scott	2007	97
4	Patient education in rheumatoid arthritis: the effectiveness of the ARC booklet and the mind map Lara D. Veeken ·David Walker, Ade Adebajo, Peta Heslop, Jackie Hill, Jill Firth, Pamela Bishop, Philip Helliwell	2007	51
5	Regional Examination of the Musculoskeletal System (REMS): a core set of clinical skills for medical students Lara D. Veeken ·David Coady, David Walker, Lesley Kay	2004	41
6	A continuous patient activity monitor: validation and relation to disability Physiological Measurement ·David Walker, Peta Heslop, Chris Plummer, T Essex, Susan Chandler	1997	23
7	Brain and Spinal Tumors of Childhood David Walker, Giorgio Perilongo, J Punt, Roger Taylor	2004	19
8	Are fibromyalgia patients as inactive as they say they are? Clinical Rheumatology ·Graham Raftery, Matthew Bridges, Peta Heslop, David Walker	2009	15
9	Does genetic anticipation occur in familial rheumatoid arthritis? Annals of the Rheumatic Diseases ·Chris Deighton, Peta Heslop, J. E. R. McDonagh, David Walker, G. Thomson	1994	13
10	Use of structured musculoskeletal examination routines in undergraduate medical education and postgraduate clinical practice – a UK survey BMC Medical Education ·Kenneth F. Baker, Sharmila Jandial, Ben Thompson, David Walker, Ken Taylor, Helen Foster	2016	12
11	A national survey of nurse training: Confidence and competence in educating patients commencing methotrexate therapy Musculoskeletal Care ·Sandra Robinson, Andrew Hassell, Sarah Ryan, Nicola Adams, David Walker	2017	11
12	Generalism versus subspecialization: changes necessary in medical education. PubMed ·W L Albritton, Joanna Bates, Michel Brazeau, Nick Busing, J. T. Clarke, Dennis Kendel, Karen McClean, Danielle Saucier, Ashley Waddington, David Walker, Jean Gray	2006	10
13	Spontaneous ambulatory activity as a quantifiable outcome measure for osteoarthritis of the knee Lara D. Veeken ·David Walker, Peta Heslop, L Kay, Colin Chandler	1998	9
14	Spontaneous ambulatory activity as a quantifiable outcome measure for rheumatoid arthritis Lara D. Veeken ·David Walker, Elizabeth Kidd, Peta Heslop, Colin Chandler	1999	8
15	Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2) Modern Rheumatology ·Tsutomu Takeuchi, Tsukasa Matsubara, Tatsuya Atsumi, Koichi Amano, Naoki Ishiguro, Eiji Sugiyama, Kunihiro Yamaoka, Mark C. Genovese, Kenneth Kalunian, David Walker, Jacques‐Eric Gottenberg, Kurt de Vlam, Beatrix Bartók, Alena Pechonkina, Akira Kondo, Jie Gao, Ying Guo, Chantal Tasset, John S. Sundy, Yoshiya Tanaka	2020	8
16	Libertas: rationale and study design of a multicentre, Phase II, double–blind, randomised, placebo–controlled investigation to evaluate the efficacy, safety and tolerability of locally applied NRL001 in patients with faecal incontinence Colorectal Disease ·Laurent Siproudhis, D. B. Jones, Richard Ng Kwet Shing, David Walker, J H Scholefield	2014	6
17	The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies Arthritis Research & Therapy ·Clifton O. Bingham, David Walker, Peter Nash, Sang Hyuck Lee, Lei Ye, Hao Hu, Javaria Mona Khalid, Bernard Combe	2022	6
18	Libertas: a phase II placebo-controlled study of NRL001 in patients with faecal incontinence showed an unexpected and sustained placebo response International Journal of Colorectal Disease ·Laurent Siproudhis, W. Graf, Emmanuel Ameyaw, David Walker, Richard Ng Kwet Shing, C. Pediconi, Jeff Pilot, Steven D. Wexner, J H Scholefield	2016	5
19	An exploration of the experiences of rheumatology nurses counselling patients on methotrexate therapy Musculoskeletal Care ·Sandra Robinson, Sarah Ryan, Nicola Adams, Andrew Hassell, David Walker	2018	5
20	Predicting responses in patients with rheumatoid arthritis to disease-modifying agents using baseline clinical data. Clinical and Experimental Rheumatology ·Nicola Gullick, Aneela Mian, Fowzia Ibrahim, David Walker, Andrew Hassell, Patrick Kiely, David A. Walsh, Adam Young, David L. Scott, Titrate Programme Investigators	2017	5

About David Walker

David Walker is a scholar working on Rheumatology, Genetics, Hematology, Pathology and Forensic Medicine and General Health Professions, having authored 53 papers that have together received 753 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (22 papers), Chronic Lymphocytic Leukemia Research (14 papers), Autoimmune and Inflammatory Disorders Research (8 papers), Systemic Lupus Erythematosus Research (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Innovations in Medical Education (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Rheumatology (465 citations), Hematology (239 citations), Genetics (141 citations), Family Practice (19 citations) and Rehabilitation (55 citations). David Walker has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Peta Heslop, Ying Guo, Beatrix Bartók, Kenneth Kalunian, Tsutomu Takeuchi, Chantal Tasset, Jie Gao, Andrew Hassell, John S. Sundy and Neelufar Mozaffarian. Their work appears in journals such as Lara D. Veeken, Annals of the Rheumatic Diseases, Musculoskeletal Care, Clinical Rheumatology and Journal of Crohn s and Colitis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact